EUCTR2016-003606-14-GB进行中（未招募）1 期
Do bisphosphonates alter the skeletal response to mechanical stimulation in children with osteogenesis imperfecta? - BAMES study
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 4-16 years
- •Able to speak fluent English
- •Diagnosed with osteogenesis imperfecta
- •Able to stand
- •Not treated with bisphosphonates
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 15
- •F.1.2 Adults (18-64 years) no
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
排除标准
- •Presence of other chronic illnesses
- •Balance problems
- •Recent fracture (in the last 6 months)
- •Recent (last 12 months) or current treatment likely to affect bone – this does not include inhaled or intermittent oral therapy with steroids for asthma
- •Involvement in another interventional research project
研究者
相似试验
已完成
2 期
Comparison of the effect of Bisphosphonate on the prevention of type 2 diabetes among Osteopenic menopause prediabetes women and Referred to Isfahan Endocrine and Metabolism Research Center.Prediabetes.Impaired glucose tolerance, Menopausal and other perimenopausal disorders, Postmenopausal osteoporosisR73, N95,IRCT2016101530309N1Vice chancellor for research, Isfahan University of Medical Sciences60
已完成
不适用
Effect of treatment with an oral bisphosphonate on markers of bone formation and bone resorption in adults with alkpatonuriaISRCTN12672997niversity Medical Centre Utrecht (UMCU) (The Netherlands)6
已完成
不适用
The effects of bisphosphonates on disease activity and bone status in ankylosing spondylitis (BIAS)Ankylosing Spondylitis (AS)Musculoskeletal DiseasesISRCTN87639321Royal National Hospital for Rheumatic Diseases (UK)180
招募中
不适用
The Effect of Bisphosphonates on the Immune System in Adults With OsteoporosisImmune systemMusculoskeletal - OsteoporosisInflammatory and Immune System - Other inflammatory or immune system disordersOsteoporosisACTRN12614000300673Bone Research Group, Garvan Institute of Medical Research44
进行中（未招募）
1 期
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects. Subtitle: A 2-year randomised parallel group trial of alendronate, ibandronate and risedronate for postmenopausal osteoporosis in secondary care. - TRIOMedDRA version: 8.1Level: PTClassification code 10031285Term: Osteoporosis postmenopausalOsteoporosisEUCTR2006-004738-33-GBSheffield Teaching Hospitals NHS Foundation Trust